Loading organizations...
Poseida Therapeutics has raised $312.5M across 4 funding rounds.
Poseida Therapeutics has raised $312.5M in total across 4 funding rounds.
Poseida Therapeutics has raised $312.5M across 4 funding rounds. Most recently, it raised $110.0M Series D in June 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 25, 2020 | $110M Series D | Fidelity Management & Research Company | Adage Capital Management, Schonfeld Strategic Advisors | Announced |
| Apr 22, 2019 | $142M Series C | Novartis Pharma | Aisling Capital, Boxer Capital, Longitude Capital, Malin Corporation, Pentwater Capital Management, Perceptive Advisors, Vivo Capital | Announced |
| Apr 3, 2018 | $30.5M Series B | David Hirsch | Malin Corporation, Tavistock Group, Vivo Capital | Announced |
| Dec 16, 2015 | $30M Series A | Adrian Howd | — | Announced |
Poseida Therapeutics has raised $312.5M in total across 4 funding rounds.
Poseida Therapeutics's investors include Fidelity Management & Research Company, Adage Capital Management, Schonfeld Strategic Advisors, Novartis Pharma, Aisling Capital, Boxer Capital, Longitude Capital, Malin Corporation, Pentwater Capital Management, Perceptive Advisors, Vivo Capital, David Hirsch.
